Area of research
Immunology · Oncology
Research interest
Research interests include Immune Cell Function and Interaction, Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, and CAR-T cell therapy research.
RBD- specific Th1 responses are associated with vaccine-induced protection against SARS-CoV-2 infection in patients with hematological malignancies
<i>Escherichia coli</i> –Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer
Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis
T-cell bispecific antibodies in node-positive breast cancer: novel therapeutic avenue for MHC class I loss variants
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
Predictors of responses to immune checkpoint blockade in advanced melanoma
Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects
Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanoma
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
NCR3/NKp30 Contributes to Pathogenesis in Primary Sjögren’s Syndrome